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THE continuous recording of phosphorus (32p) uptake by way of counters
embedded in a tumour was first described by Hale (1961). Further developments
in instrumentation and practical findings in respect of human tumours were
described by Bullen, Freundlich, Hale, Marshall and Tudway (1963). Among
the findings were the occurrence of distinct peaks and troughs in the count rate
from some tumours, the possibility of inducing such variations in activity in
other tumours, and, on the basis of clinical experience, that a peak in activity
coincided with a period of relative radiosensitivity whilst a trough in activity
coincided with a period of relative radio-insensitivity. The above work was
carried out on human patients.
The present paper describes some more technical developments and the
application of these techniques to transplanted experimental tumours in rats.
This latter work has been undertaken with the idea of making more detailed
investigations, particularly from the biochemical aspect, than are feasible with
human material.
PHYSICAL ASPECTS
Counters
Throughout the work described, the detector has been a Mullard Geiger-
Muller counter, type MX151. These halogen-quenched counters have an overall
diameter of 5 mm. and active length of 17 mm. but for use in vivo they have to
be hermetically encapsulated. Initially the G.M. tube, together with its load
resistor, was encapsulated within a perspex tube of wall thickness 0-015 in. over
the active length. This adds a further 45 mg./cm.2 to the 90 mg./cm.2 wall of
the counter. The 10 Megohm load resistor was bonded directly to the tube anode
and the cathode to the earthed braid ofthe polythene-sheathed miniature co-axial
cable, using a conducting epoxy paste. Direct mounting of the load resistor on
the tube anode gives least possible anode capacitance and hence best tube life.
The whole assembly was then encapsulated within the Perspex tube using Araldite
Resin AY103 and Hardener HY951 (Fig. 1). To ensure a hermetic seal, recom-
mended degreasing and abraiding instructions were followed for all surfaces.
The resin was cured at room temperature to avoid damage to the counter. With
this technique, the overall size ofthe counter becomes 8 mm. diameter and 45 mm.
in length. An alternative packaging which reduces this diameter and improves32P COUNTING OF TUMOURS
the sealing is being tried using heat-shrinking plastics and this achieves an overall
diameter of 6 mm.
Each counter is routinely tested on completion to check the seal and reliability
by immersion in a solution of 32p for a period of 24-48 hours. Typically these
counters have a plateau length greater than 200 V and plateau slope less than
0.1% volt. Working at 50 V above threshold they have a sensitivity of 330 ± 30
c/sec./IuCi/ml. for 32p.
The 32p ,-particles of maximum energy have a tissue range of 8 mm. How-
ever, because of the continuous spectrum of fl-energy the effective range is
considerably smaller. Approximately 90% of all counts arise from a 21 mm.
thick layer of tissue concentric with the counter. This represents a "sampled
volume " of about 1-5 ml.
MX 151 G.M. COUNTER.
1O MEGOHM ANODE RESISTOR.
POLYTHENE SHEATHED CO-AX.
CATHODE CONNECTION.
PERSPEX CAPSULE.
1CM.
I
FIG. I -Assembly of the Mullard MX151 counter.
Potentially, halogen-quenched MX151 G.M. tubes have a very good life
expectancy; laboratory accelerated life tests have yielded lives exceeding 109
counts. When these counters are used in-vivo however, the life is of the order of
5 x 107 counts, failures being usually due to mechanical faults or damage rather
than by the end of count life.
In our practical usage the nature of the Geiger pulses observed is wholly
determined by the external circuit. Measurements of the true anode pulse were
made (using a fast pulse amplifier with capacity-corrected attenuator) in order
to construct test generators of good simulation. Rise times within the range
0 5-3 ,tsec. and fall times of about 50 ,usec. were found, with peak amplitudes
at 50 V above threshold voltage) of about 270 volts.
Electronic system
This consists, for each counter, of a solid state pulse pre-amplifier, and a
modified commercial thermionic ratemeter which provides (besides stabilised
E.H.T. for the G.M. tube) a d.c. output which is proportional to the smoothed
average count rate. This output may be fed to a single channel recorder or, in a
multi-channel system, to one input of a multi-point potentiometric recorder.
The pre-amplifier (Fig. 2) employs a low input-impedance transistor circuit, and
operates on the current pulse defined by the counter discharge and the counter
anode resistor. An advantage ofthis arrangement is that relatively large lengths
439440 G. CALCUTT, M. A. BULLEN, D. H. MARSHALL AND T. J. GODDEN
(up to 50 m.) of co-axial cable may be used between counter and pre-amplifier
avoiding the need for any electronic unit near to the animal or patient. Cable
capacity slows pulse duration to the order of 150 ,usec. but this is no drawback
with the low count rates (1-3 c/sec.) encountered. High pre-amplifier gain gives
limiting and standard -3 V output pulses are passed to the ratemeter. Some
discrimination against spurious pulses is given by the non-linear operation of T3.
The ratemeters we have used are commercial thermionic units (N522 and 1815)
with certain modifications. E.H.T. source impedance has been raised to 10
Megohm to limit the value of any accidental short-circuit current to some 40 jA.
Full scale count rate values have been reduced, the ranges now being 0-1, 0-3,
E.H.T
200-800v Dc.
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SOKT O1IF ipF OUTPUT 6vA
IOOOvDLC. lO 3 1 3KiK 0p
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FIG. 2.-Pulse pre-amplifier circuit.
0-10, etc. c/sec. Finally, a long-time constant of 800 seconds is used. This
value is a compromise between two opposing requirements-the need to minimise
(with our low count rates) statistical fluctuation of the record by using a long
effective time, and the need to avoid distortion ofrapid real changes of count rate.
The 800 second time-constant is realised in practice by increasing the task-circuit
resistor to 10 Megohm and using low leakage polyethylene terephthalate dielectric
capacitors of 40 ,uF, with a d.c. amplification of x 2. The 50 mV full scale d.c.
output is fed to one input of a multi-input self-balancing recorder. When more
than three channels are in use it is convenient to employ automatic switching so
that traces are displayed in two side-by-side zones, thus avoiding excessive trace
overlap. The recorder chart speed is 10 mm./hour, and each ratemeter output
is sampled and printed once every 4 minutes.
Test units have been constructed which provide pulses similar to the G.M.
tube pulses, at pre-selected stable repetition rates. These units are useful for
routine checks of the stability and accuracy of the whole system.32P COUNTING OF TUMOURS
Counting statistics
The random nature of radioactive disintegration leads to a statistical
uncertainty in any activity measurement. If a series of measurements is taken
the dispersion of the readings can be described by a Poisson distribution. The
spread of the readings about the mean value is a function of the rate of counting
and of the period of observation; for measurements made with a ratemeter the
standard deviation (oC) of any reading is given by o- = (2rT)-'12 where r is the
mean count rate and T is the ratemeter time constant. The probability is that
1 reading in 3 will be outside the band r ± o-. A more useful criterion to assess
small fluctuations in the count rate for reality is to consider readings outside the
r ± 3o- band, where the expectation for a purely random excursion would be
only 1 in 370. Hence a consecutive series of readings outside the 3o- band about
the mean value of previous readings (over a time which is long in comparison
with the ratemeter time constant) will be highly significant of a change in the
measured system (as in Fig. 4b).
Where the change in the system persists for a long period (as in Fig. 5b) the
significance of the change can be assessed by calculating the difference in the
mean levels over long periods in terms of standard deviations.
APPLICATION OF TECHNIQUE
Materials and Methods
Two separate tumours have been used; an osteosarcoma originally of spon-
taneous occurrence and a fibrosarcoma initially induced with 3,4-benzopyrene.
Both tumours are transplanted in rats of the August strain. For experimental
use the transplants have been in the flank of animals of either sex and of ages
varying between 100 and 300 days.
The counters were inserted into the tumours through a skin incision and the
connecting cable was passed back below the skin to emerge from a small incision
on the dorsal surface at the base ofthe tail. The connecting lead was then firmly
taped to the tail with surgical tape. All surgical procedures were carried out
under a combination of nembutal and ether anaesthesia with aseptic precautions.
A length ofwide bore glass tubing was passed over the tail and lead, and connection
by way of soldered joints made to a long cable. The rat was maintained in a
polythene bucket and was effectively restrained by tying the cable at a point
vertically overhead and by clamping the glass tubing so that it was firmly held
over the tail. Under these conditions the animals were prevented from gnawing
at the cable and yet remained in excellent health over periods of up to 15 days.
The 32p was given by intraperitoneal injection of a solution of radioactive
sodium phosphate in distilled water atthe rate of 1 /tCi per 100 g. of body weight.
This dosage gave a suitable counting rate. Drugs used for experimental purposes
have all been given by intraperitoneal injection. Details of dosages are given in
the appropriate section below.
EXPERIMENTAL FINDINGS
After dosage with 32p uptake has been rapid and a steady counting rate
achieved after about 2 hours. Within 24-48 hours after insertion of the counter
into the tumour and treatment with 32p a regular pattern of counting has been
achieved. This has normally been a steady rate showing only those irregularities
441442 G. CALCUTT, M. A. BULLEN, D. H. MARSHALL AND T. J. GODDEN
to be expected as a result ofthe random decay ofthe 32p. A tracing of a normal
recording is shown at Fig. 3a. The parallel lines denote the extremes of random
variation of count-rate, being +3 standard deviations from the local mean value.
The age or sex of the host carrying the transplant appears to have had no effect
upon either the count rate or the pattern of counting.
In a number of tracings significant spontaneous variations of count-rate have
been seen. An example is shown in Fig. 3b, in which the parallel lines again
3a 2-5
j2c/s
3b 1.5~~~~~~~ic/s
I0-5
40 30 20 10 0
E- HOURS
FIG. 3a.-Normal trace from osteosarcoma.
b.-Trace showing spontaneous peaking-fibrosarcoma.
Read from right to left.
denote the statistical limits of variation. Many regular variations of approxi-
mately 1L hour period are present, superimposed on a large slower circadian
rhythm. In other tracings rhythms ofabout 12 hour periods have been observed,
both with and without faster components.
Numerous attempts have been made to induce rhythmic variations in the
count rate as Bullen et al. (1963) have shown is possible with some human tumours.
Methotrexate has been given in single or multiple doses at various levels ranging
between 0-6 mg./kg. bdy.wt. and 10.0 mg./kg. bdy.wt. No example of any
satisfactory response has been obtained.
Treatment with a number of physiologically important compounds has been
undertaken to see if they influence the counting rate. Sucrose (10 g./kg.32p COUNTING OF TUMOURS
bdy.wt.) insulin, vasopressin and corticosterone have had no effects on the
counting rate. Somatotrophin, which might be expected to cause the tumours
to grow faster does increase the counting rate for several days after a single dose
of 1 i.u. There is a delay of 24 hours between treatment and the appearance of
the enhanced count rate. Both tumours behave similarly.
Because ofthe clinical evidence ofvariations in radiosensitivity in accord with
the occurrence of peaks and troughs in the count rate from a tumour tests of
known radioprotective and radiosensitising agents have been made with this
system.
Cysteine was shown by Patt, Tyree, Straube and Smith (1949) to be an effective
radioprotector. It was given in neutralised solution at the maximum tolerated
dose of 1 g./kg. bdy.wt. No immediate effect on the counting rate occurred in
either tumour. In some but not all cases a slightly increased counting rate
became apparent about 24 hours after treatment. This effect lasted for 3-4 days
and then the count rate returned to a normal level.
Cysteamine (,f-mercaptoethylamine) was first described as a radioprotective
agent by Bacq, Herve, Lecomte, Fischer, Blavier, Deschamps, Le Bihan and
Rayet (1951). It was given in buffered solution at pH 7-5 at a dosage of 125
mg./kg. bdy.wt. It caused a rapid and obviously statistically significant fall in
the count rate from either tumour (Fig. 4). Recovery to a normal level was
also rapid. The time of the maximum depression of counting was 3 1 hour after
treatment.
2 Aminoethylisothiouronium bromide (A.E.T.) was considered by Doherty
and Burnett (1955) to be a more active protector than cysteamine. This was
used at a dosage of 300 mg./kg. bdy.wt. and was found to induce similar effects
to those obtained with cysteamine (Fig. 4b). Again the timing was similar to
that with cysteamine.
2,4-Dinitrophenol, apart from its well known uncoupling action on oxidative
phosphorylation, is also a radioprotective agent (Praslicka, Hill and Novak,
1962). This was used at the rate of 6 mg./kg. bdy.wt. and resulted in a rapid
fall in the counting rate (Fig. 4c). Return to a normal level did not take place
until 48 hours had elapsed.
Since three out of the four radioprotective agents used caused a reduction in
the 32p counting rate, several claimed radiosensitisers were also tested to see if
they increased the counting rate. The results in these tests have not been so clear
cut.
Neither iodoacetic acid (40 mg./kg. bdy.wt.) found to be a radiosensitiser of
mice by Langendorff and Koch (1954) nor p-chloromercuribenzoic acid (18 mg./kg.
bdy.wt.) found to radiosensitise mice by Patt, Mayer and Smith (1952) had any
influence on the count rate from either tumour. Stein and Griem (1958) found
L-triiodothyronine to radiosensitise a rat chloroleukaemia. This was given in a
single dose of 0-2 mg./kg. bdy.wt. and resulted in a slight rise in the count rate
about 1- hours after treatment (Fig. 5a). Synkavite (tetrasodium-2-methyl-1-4-
naphthohydroquinone diphosphate) was first introduced by Mitchell (1948).
Since that time various conflicting reports as to its effectiveness have appeared
(see Foye, 1963). It was used as a single dose at the rate of 100 mg./kg. bdy.wt.
and caused a small increase in the counting rate for several hours after treatment
with both tumours (Fig. 5b). This rise in counting rate could be obtained
repeatedly. The mean levels were assessed over periods of 3 hours, before
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administration of Synkavite, and after the resulting rise had stabilised. Stating
errors in terms of +2 standard deviations (corresponding to a 95% confidence)
the mean level before administration was 1-17 0 04 c./sec., while the mean final
level was 1-36 + 0-04 c./sec. Thus, although the rise is only about 15%, it has
high reality.
4a
1-5
4b 2-5
~~~~~~~~~~~~- c/s
11q5
4c
16
a I 12 8 4
I_
15
1c/s
J0*5
0
- HOURS
FIG. 4a.-Effect of 125 mg./kg. cysteamine-fibrosarcoma.
b.-Effect of 300 mg./kg. A.E.T.-osteosarcoma.
c.-Effect of 6 mg./kg. 2,4-dinitrophenol-osteosarcoma.
Read from right to left.
2-532P COUNTING OF TUMOURS
5a
j2c/s
5h 3
I 1~~~~~~~ 2cls
-~~~~~~~~~~~~
10 8 6 4 2 0
HOURS
FIG. 5a. Effect of 0-2 mg./kg. triilodothyronine-fibrosarcoma.
b.-Effect of 100 mg./kg. Synkavite osteosarcoma.
Read from right to left.
The most frequently used method for the sensitisation of tumour cells to
irradiation is to increase oxygenation. In some preliminary trials the rats have
been maintained for periods up to 1 hour in oxygen at 1 atmosphere pressure.
This has had no effects on the counting rate from either tumour.
DISCUSSION
The results described above have been obtained with two tumours and one
stirain of rat. Under these circumstances too much value must not be placed on
them. Nevertheless, certain points of interest have become apparent.
It has been clearly shown that the technique of counting of 32p from tumours,
originallv developed for use with human patients, can be satisfactorily applied to
transplanted tumours in small animals. The only specific requirement would
appear to be the use of solid tumours which grow sufficiently large to allow a
thickness of 8 to 10 mm. between the counter and any normal body structure.
This is to avoid counting from normal tissues. This requirement has been met
in the present experiments since both tumours grow to a considerable size without
the occurrence of large masses of necrotic tissue.
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Under normal circumstances the counting rate has followed an expected
pattern of regularity consistent with the effective decay of the isotope. This fact
in itself has made the system an excellent one for testing the effects of extraneous
agents. Exceptionally, spontaneous fluctuations were encountered in the count
rate with a timing of approximately two hours between peaks. A similar timing
was found by Bleehen, Bryant and Gallear (1965) to occur between spontaneous
peaking found in the count rate from hormone dependent carcinogen induced
mammary tumours in Sprague-Dawley rats. Although this timing differs
considerably from the 13 hour mean interval found between peaks in humans by
Hale (1961) the occurrence of rhythms of about 12 hours period in some tracings
suggests that the behaviour of 32p in rat tumours runs parallel to that of 32p in
human tumours.
Ofthe four radioprotective agents used three caused a fall in the counting rate,
a fact which appears consistent with the clinical experience that a trough in the
counting rate is associated with a period of relative radio-insensitivity. Experi-
ence with 2,4-dinitrophenol is interesting since the counting rate was depressed
over a long time. Although usually regarded as an acute poison, Dianzani and
Scuso (1956) found that the uncoupling effect of 2,4-dinitrophenol on rat tissues
persisted for more than 20 hours. This, however, was not confirmed by Parker
(1956). The present results certainly indicate that an upset in phosphorus levels
induced by 2,4-dinitrophenol can persist for a long period.
The fact that cysteine failed to have an immediate effect on the counting rate
may or may not be significant. It is possible that the cysteine failed to reach the
tumour. This explanation receives some support from the fact that in a limited
series of experiments with the fibrosarcoma it was found that cysteine at a dosage
of 1 g./kg. bdy.wt. failed to increase the non-protein sulphydryl level of the
tumour up to 1 hour after treatment. During the same interval the non-protein
sulphydryl levels of the liver and spleens of the same rats increased considerably.
Alternatively, it is possible that the protection afforded by cysteine is mediated
by a different mechanism from that afforded by cysteamine or A.E.T. Such a
possibility has been suggested by Bacq (1965) and is further supported by con-
sideration of the vastly greater (in terms of available thiol) amount of cysteine
required to give protection as compared with other thiol protectors.
The increased counting rate found on occasion after a single dose of cysteine
might be associated with an increased growth rate of the tumour. Haddow
(1958) has shown that single doses of thiol compounds can induce an increased
tumour growth rate.
Results obtained with the radiosensitisers show the interesting feature that
both caused a small rise in counting rates. This would appear to be in agreement
with the clinical findings. Failure ofthe other agents used to alter the 32pcounting
rate does not signify that they are useless, it merely means that they have not
altered the levels of 322p in the currently used tumours.
The present work enables it to be said that the levels of phosphorus in experi-
mental tumours are not necessarily constant, may show spontaneous rhythms
and can be significantly altered by external agents. The alteration of phosphorus
levels by agents altering radiosensitivity raises the new question of the role of
intracellular phosphorus in tissue response to irradiation. Further work along
the present lines would appear desirable as it seems likely to open new prospects
in terms of radiation biochemistry and offer a basis for further experimental work
aimed at elucidation of clinical findings.32p COUNTING OF TUMOURS 447
SUMMARY
The physical background and instrumentation for the continuous counting of
32p from tumours has been described. The application of these methods in the
case of two transplantable tumours in August rats is outlined. The effects of a
number of physiologically important agents and some known radioprotective or
radiosensitising agents on 32p counting rates have been examined. The findings
are discussed.
We are indebted to Dr. R. C. Tudway and Dr. B. T. Hale for much helpful
discussion; to D. Bussell, L. A. Daynes, A. S. Burleton and Miss S. Wheeler for
technical assistance and to F. Butcher for his care of the animals.
The expenses of this work have been defrayed from a block grant to Mount
Vernon Hospital from the British Empire Cancer Campaign for Research, and
grants to Bristol General Hospital from the British Empire Cancer Campaign
for Research, the Medical Research Council, the United Bristol Hospitals and the
Damon Runyon Memorial Fund.
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